T5	Subject 10 49	a patient with a colonic adenocarcinoma
T7	Effect 64 89	hemolytic uremic syndrome
T8	Treatment 106 126	85 mg/m2 of the drug
T9	Sub-Disorder 27 49	colonic adenocarcinoma
T10	Dosage 106 114	85 mg/m2
